The kidney transplant: New horizons

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 3, 2010, Pages 260-265

  Mengel, Michael ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Allograft failure; Banff classification; Kidney allograft; Pathology

Indexed keywords

DISEASE CLASSIFICATION; GLOMERULONEPHRITIS; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; REVIEW;

GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 77951499782     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283381ea5     Document Type: Review

References (45)

1. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44:411-422.
2. Campistol JM, Boletis IN, Dantal J, et al. Chronic allograft nephropathy-a clinical syndrome: early detection and the potential role of proliferation signal inhibitors. Clin Transplant 2009 [Epub ahead of print].
3. Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplant 2006; 81:643-654.
4. Seron D, Arns W, Chapman JR. Chronic allograft nephropathy: clinical guidance for early detection and early intervention strategies. Nephrol Dial Transplant 2008; 23:2467-2473.
5. Cook HT. The origin of renal fibroblasts and progression of kidney disease. Am J Pathol 2010; 176:22-24.
6. Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 2007; 22:2011-2022.
7. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases: insights from animal models. Kidney Int 2005; 67:404-419.
8. Le Hir M, Besse-Eschmann V. A novel mechanism of nephron loss in a murine model of crescentic glomerulonephritis. Kidney Int 2003; 63:591-599.
9. Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7:518-526.
10. Feucht HE. Complement C4d in graft capillaries: the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3:646-652.
11. Bohmig GA, Exner M, Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13:1091-1099.
12. El Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005; 66:989-997.
13. Halloran PF, Wadgymar A, Ritchie S, et al. The significance of the anticlass I antibody response. I. Clinical and pathologic features of anticlass I-mediated rejection. Transplant 1990; 49:85-91.
14. Halloran PF, Schlaut J, Solez K, SrinivasaNS. The significance of the anticlass I response. II. Clinical and pathologic features of renal transplants with anticlass I-like antibody. Transplant 1992; 53:550-555.
15. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3:708-714.
16. Sis B, Jhangri G, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9:2312-2323.
17. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713-723.
18. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7:1743-1752.
19. Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380.
20. Liptak P, Kemeny E, Morvay Z, et al. Peritubular capillary damage in acute humoral rejection: an ultrastructural study on human renal allografts. Am J Transplant 2005; 5:2870-2876.
21. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7:2124-2132.
22. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol 2002; 13:234-241.
23. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63:1888-1893.
24. Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005; 45:1084-1089.
25. Mauiyyedi S, Pelle PD, Saidman S, et al. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12:574-582.
26. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13:779-787.
27. Gibson IW, Gwinner W, Brocker V, et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008; 8:819-825.
28. Fahim T, Bohmig GA, Exner M, et al. The cellular lesion of humoral rejection: predominant recruitment of monocytes to peritubular and glomerular capillaries. Am J Transplant 2007; 7:385-393.
29. Sis B, Einecke G, Chang J, et al. Cluster analysis of lesions in kidney transplant biopsies: microcirculation changes, tubulointerstitial inflammation, and scar ring. Am J Transplant 2009 (in press).
30. Sis B, Mengel M, Haas M, et al. Banff '09 Meeting report: antibody mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 2009 (in press).
31. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9:2561-2570.
32. Toki D, IshidaH,Setoguchi K, etal. Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors. Am J Transplant 2009; 9:567-577.
33. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9:2520-2531.
34. El Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009; 9:527-535.
35. Famulski KS, Einecke G, Sis B, et al. Canonical T cell mediated rejection in human kidney transplants has a favorable prognosis even when rejection is late or has arteritis. Am J Transplant 2009 (in press).
36. Colvin RB, Cohen AH, Saiontz C, et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation. J Am Soc Nephrol 1997; 8:1930-1941.
37. Mengel M, Gwinner W, Schwarz A, et al. Infiltrates in protocol biopsies from renal allografts. Am J Transplant 2007; 7:356-365.
38. Sis B, Dadras F, Khoshjou F, etal. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006; 6:1444-1450.
39. Ojo AO, Held PJ, Port FK, etal. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-940.
40. Gourishankar S, Leduc R, Connett J, et al. Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study. Am J Transplant 2009 (in press).
41. Matas A, Leduc R, Rush D, et al. Histopathologic clusters differentiate subgroups within the nonspecific diagnoses of CAN or CR: preliminary data from the DeKAF study. Am J Transplant 2009 (in press).
42. Mueller TF, Einecke G, Reeve J, etal. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007; 7:2712-2722.
43. Mengel M, Sis B, Halloran PF. SWOT analysis of Banff: strengths, weaknesses, opportunities, and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant 2007; 7:2221-2226.
44. Mengel M, Reeve J, Bunnag S, etal. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2009; 9:169-178.
45. Mengel M, Reeve J, Bunnag S,etal. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant 2009; 9:1859-1867.